Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes…

By Silvio E. Inzucchi, R. Bergenstal, John B. Buse, M. Diamant, E. Ferrannini, M. Nauck, A. Peters, A. Tsapas, R. Wender, Matthews. Diabetes Care, 2013

1,101 citations recorded by the source corpus.

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 …

Subfields: Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/ef097f4b2216794ff00c61d693b279a0e346d8c5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

Citations in the corpus

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. (2013, background): “It is because of results like these that metformin is the recommended first hypoglycaemic agent to be used in patients with type 2 diabetes.(79) The thiazolidinediones, however, have a mixed record of success in terms of cardiovascular outcomes.”
Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics (2015, background): “decision making is a key component of patient-centered care (43,77) and has been shown to improve clinical, psychosocial, and behavioral”
Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013, background): “For patients with type 2 diabetes, sulfonylureas are the oral agents that pose the greatest risk for iatrogenic hypoglycemia and substitution with other classes of oral agents or even glucagon-like peptide 1 analogs should be considered in the event of troublesome hypoglycemia (96).”
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2014, background): “This briefer article should therefore be read as an addendum to the previous full account (1,2).”
Metformin-associated lactic acidosis: Current perspectives on causes and risk. (2016, background): “This is an open a first line therapy for newly diagnosed type 2 diabetes bymany professional diabetes organizations [1].”
Diabetes in Older Adults (2012, background): “Understanding the advantages and disadvantages of each antihyperglycemic drug class helps clinicians individualize therapy for patients with type 2 diabetes (96).”